Rus Eng
Main / Company's news / NABI: new approaches to the problem of stroke

NABI: new approaches to the problem of stroke

10 October 2014

GEROPHARM, Group of Companies took part in the 3rd Russian International Congress "Cerebrovascular pathology and stroke", which was held on 6–9 October 2014 in Kazan. This city was specifically selected for the congress: Kazan has a special significance for the development of neurological direction, as Kazan Neurological School, founded by the outstanding scientist V.M. Bekhterev, is one of the oldest and most prestigious in our country and abroad.

The congress was attended by more than 2,000 delegates and guests from all the regions of the Russian Federation, CIS countries, Europe, North America and other countries. Experts at the event were leading Russian and foreign neurologists, members of the Praesidium and the Board of the National Stroke Association, and the All-Russian Society of Neurologists, as well as representatives of national, provincial and regional health authorities. Issues at stake could be of interest to the specialists in the related disciplines, such as neurosurgeons, cardiologists, vascular surgeons, specialists in rehabilitation medicine, clinical pharmacologists, psychiatrists and representatives of basic medical sciences such as molecular biologists, geneticists, biochemists, neuromorphologists, physiologists and immunologists.

The epidemiology of cerebrovascular diseases, risk factors and pathogenesis of acute and chronic cerebrovascular disease, management of patients with acute cerebral stroke, problems of rehabilitation, as well as the primary and secondary prevention were the main scientific directions of the congress. Particular attention was paid to the introduction of the new pharmacological and invasive technologies into clinical practice, as well as organizational, pharmacoeconomic and legal aspects of the cerebrovascular disease. As it was at the previous congresses held in Moscow and St. Petersburg, the fundamental research in vascular pathologies was in the spotlight, in particular, the molecular mechanisms of damage and recovery of the nervous system, genetic, biochemical and pathophysiological mechanisms of vascular diseases.

The congress summed up the work of the National Stroke Association stroke during the past period and considered the organizational issues, making decisions on which will create conditions for further development and improvement of specialized care for patients with cardiovascular diseases in the Russian Federation.

GEROPHARM, Group of Companies organized a satellite symposium called “New possibilities in the treatment of cerebrovascular disease” for the participants of the congress. Praesidium of the symposium was headed by RAS Academician A.A. Skoromets and Professor L.V. Stakhovskaya. Professor L.B. Novikova, N.A Shamalov, V.V. Mashin, M.A. Evzelman, N.A. Aleksandrova, and Senior Staff Scientist K.S. Meshkova presented their reports to the audience.

The abstracts raised a lot of new and interesting subjects. For example, in her report, K.S. Meshkova mentioned that the use of Cortexin in two courses of 20 mg/day (10 mg + 10 mg) for the treatment of patients with ischemic stroke in the acute and early recovery periods is a cost-effective and economically feasible strategy. Whereas from the report by V.V. Mashin, the doctors learned that poststroke patients receiving therapy with Cortexin demonstrated the most marked improvement of neurological deficit and functional state of development without MODS.

The congress is traditionally accompanied by an exhibition of leading Russian and international companies, at which practitioners could learn about the achievements in the field of medical science, share their experience, and exchange ideas and contacts.

At the exhibition GEROPHARM presented its stand, which pleasantly surprised the guests with its vividness and originality. Not only did the stand enable the participants to obtain information about the medicines produced by the company, but also to participate in an entertaining quiz, try their hand at creating a bracelet of flowers during a master class, get a souvenir caricature and take a boost of energy with a cup of coffee, and a national bun. Having registered on foursquare at the company's stand, the most tech-savvy visitors received a souvenir.

Note by NABI – National Stroke Association

Concern about public health is one of the conditions for the successful development of a country. Programs aimed at the development of medicine, reduction and prevention of morbidity have been developed and are being implemented to solve this problem. Cerebrovascular pathology refers to diseases that are of great medical and social importance because of the high mortality and disability.

The National Stroke Association (NABI) was established in 1999 in the Russian Federation in order to improve the care of patients with vascular disease, the development of new methods of diagnosis, the treatment and prevention of these conditions, as well as the integration of scientific research. Over 15 years NABI, in direct contact with the Ministry of Health of the Russian Federation, the All-Russian Society for Neuroscience, the Russian Medical Society on Arterial Hypertension, the Society for clinical pharmacology and other Russian and international public health organizations, has done a great organizational and practical work to improve the health care delivery to patients with vascular disease. For the first time in this country, the systemic epidemiological studies were organized, the importance of an interdisciplinary approach to solving the problem of cerebrovascular pathology involving different specialists, such as neurologists, cardiologists, neurosurgeons, vascular surgeons, rehabilitation specialists and other professionals was demonstrated, the regional vascular centres and primary vascular departments were established, and the modern methods of stroke care were introduced, including neuroprotective and thrombolytic therapy, which contributed to a significant reduction in mortality and an increase in the number of patients independent in daily life.

The NABI congresses in Moscow in 2003 and in St. Petersburg in 2007, which involved the leading Russian and foreign experts, the organizers and leaders of the World and European Federation of Neurology, the World Stroke Organization, as well as other domestic, international and foreign medical organizations, were of particular importance for the development of cerebrovascular disease patient care, identifying further areas of research.

You are a health care professional?

Go up